AMRI increases hydroxychloroquine sulfate production to meet COVID-19 demand
AMRI, the US pharmaceutical research and development and manufacturing contractor, said it has obtained an emergency authorization from the US Food and Drug Administration (FDA) to increase the production of the malaria drug hydroxychloroquine sulfate, which is identified as a potential treatment for COVID-19.
The company said it will use the production facility in Rensselaer (production of hydroxychloroquine sulfate) to cope with rising market demand for the product.
At present, AMRI has active type II dimethylformamide for the production of hydroxychloroquine sulfate, which can meet the rising demand. The FDA authorized the emergency use of hydroxychloroquine sulfate in March to treat some patients with new coronary pneumonia admitted to the hospital.
You May Interested In
2026-09-24
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pfizer's paxlovid reduces the risk of COVID-19 by 26%
-
The battle between Pfizer and Gilead over COVID-19 drugs will continue
-
1200 cases were newly prescribed by Junshi Biologic for mild to moderate disease
-
Twenty-five COVID-19 Vaccines In China Enter Stages Of Clinical Trials
-
Pfizer to Increase Production Capacity of COVID-19 Oral Drugs, Invest 120 Million US Dollars
-
Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant Strains Such as COVID-19 Omicron
-
As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid Generic Drug Price Released
-
Survey On Corona Deaths By Country
-
COVID-19 Drug Remdesivir Approved for Infants And Young Children
-
Roche's Q1 Performance Increases by 10%, And Total Revenue for the Year May Slow Down Due to COVID-19, Biosimilar Competition
Recommend Reading
-
![South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%]()
South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%
-
![“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function]()
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function
-
![India Approves ₹30.3 Billion Chemical-Park Scheme to Build Three Mega Industrial Hubs]()
India Approves ₹30.3 Billion Chemical-Park Scheme to Build Three Mega Industrial Hubs
-
![EFSA’s Updated Food-Additive Application Guidance Takes Effect]()
EFSA’s Updated Food-Additive Application Guidance Takes Effect
-
![FDA Revokes Orange B Authorization and Proposes Removing Citrus Red No. 2]()
FDA Revokes Orange B Authorization and Proposes Removing Citrus Red No. 2
-
![July China Marine Fuel Market Rises]()
July China Marine Fuel Market Rises
-
![In July, China's propylene oxide market showed a trend of first declining, then rising, and finally surging before stabilizing]()
In July, China's propylene oxide market showed a trend of first declining, then rising, and finally surging before stabilizing
-
![July Titanium Dioxide Market Prices Decline]()
July Titanium Dioxide Market Prices Decline
-
![US-Iran Signals Easing, Plasticizer Supply Chain Stabilizes]()
US-Iran Signals Easing, Plasticizer Supply Chain Stabilizes
-
![Melamine Stops Falling and Begins to Rebound; Short-Term Trend Strengthens; Golden Cross Awaits Confirmation]()
Melamine Stops Falling and Begins to Rebound; Short-Term Trend Strengthens; Golden Cross Awaits Confirmation
